original ) (raw )OC.13.3: Metformin Inhibits Proliferation, Enhances Apoptosis and Down-Regulates Epithelial to Mesenchymal Transition (EMT) in Human Cholangiocarcinoma (CCA): A Study on Human Primary Cell Cultures
sabina di matteo
Digestive and Liver Disease, 2017
View PDFchevron_right
MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patients
Chun-nan Yeh
Oncology Reports
View PDFchevron_right
Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition
Paul Morrison
Cytokine & Growth Factor Reviews, 2002
View PDFchevron_right
Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: its specific receptor c-met does
antonio ponzetto
Hepatology (Baltimore, Md.), 1996
View PDFchevron_right
Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma
JACK CHAN
Diseases, 2015
View PDFchevron_right
Overexpression of c-met Protooncogene Product and Raised Ki67 Index in Hepatocellular Carcinomas With Respect to Benign Liver Conditions
Antonio Ponzetto , Tiziana Crepaldi , antonio ponzetto
View PDFchevron_right
Metformin Inhibits Migration and Invasion of Cholangiocarcinoma Cells
Son Trinh
Asian Pacific journal of cancer prevention : APJCP, 2017
View PDFchevron_right
Review Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma
JACK CHAN
2016
View PDFchevron_right
The HGF Receptor c-Met Is Overexpressed in Esophageal Adenocarcinoma1
Siva Raja
View PDFchevron_right
The HGF Receptor c-Met Is Overexpressed in Esophageal Adenocarcinoma
Siva Raja
Neoplasia, 2005
View PDFchevron_right
Focal adhesion kinase and Src phosphorylations in HGF-induced proliferation and invasion of human cholangiocarcinoma cell line, HuCCA-1
vijittra leardkamolkarn
World journal of gastroenterology : WJG, 2005
View PDFchevron_right
Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor
Robert Wondergem , D. Defoe
International Journal of Cancer, 1998
View PDFchevron_right
Invasiveness of Hepatocellular Carcinoma Cell Lines: Contribution of Hepatocyte Growth Factor, c-met, and Transcription Factor Ets1
yan jiang
Biochemical and Biophysical Research Communications, 2001
View PDFchevron_right
Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: A link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma
Andrea Ferreira-gonzalez
Hepatology, 1999
View PDFchevron_right
Targeting PDGFR-β in Cholangiocarcinoma
Joachim Mertens
Liver International, 2011
View PDFchevron_right
TGF-β signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures
Alfredo Cantafora
PLOS ONE
View PDFchevron_right
c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target
Ken ITO
BMC cancer, 2015
View PDFchevron_right
The c-Met Inhibitor MSC2156119J Effectively Inhibits Tumor Growth in Liver Cancer Models
Christian Ihling
Cancers, 2014
View PDFchevron_right
The Emerging Role of c-Met in Carcinogenesis and Clinical Implications as a Possible Therapeutic Target
Livia Onofrio
Journal of Oncology
View PDFchevron_right
Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β1/Snail Activation Aggravates Invasive Growth of Cholangiocarcinoma
Valentina Dell'Oste
The American Journal of Pathology, 2010
View PDFchevron_right
Modulation of the c-MET/hepatocyte growth factor pathway in small cell lung cancer
Geoffrey Shapiro
Clinical Cancer Research
View PDFchevron_right
Inhibition of c-Met as a Therapeutic Strategy for Esophageal Adenocarcinoma
Pierre Oliveira
Neoplasia, 2006
View PDFchevron_right
Application of Biological Study for Met Expression to Cancer Therapy
Kazuhiro Yoshida
Anti-Cancer Agents in Medicinal Chemistry, 2010
View PDFchevron_right
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
Donald Bottaro , Jeffrey Rubin
Science, 1991
View PDFchevron_right